MoneyWorks4Me

Zydus Lifesciences informs about investor conference

14 Feb 2024 Evaluate

Zydus Lifesciences has informed that the Company is going to participate in an investor conference ‘Kotak’s Chasing Growth 2024’ at Mumbai on Monday, February 19, 2024. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1113.50 -3.50 (-0.31%)
19-Aug-2026 12:05 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1894.80
Dr. Reddys Labs. 1177.70
Cipla 1423.40
Lupin 2205.00
Zydus Lifesciences 1113.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: